Inovio Pharmaceuticals
INO
INO
96 hedge funds and large institutions have $65.1M invested in Inovio Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13.69% more ownership
Funds ownership: 17.4% → 31.1% (+14%)
8% more funds holding
Funds holding: 89 → 96 (+7)
Holders
96
Holding in Top 10
–
Calls
$2.93M
Puts
$1.98M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$11M | |
| 3 | +$2.83M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.67M |
| 5 |
Bank of New York Mellon
New York
|
+$661K |
Top Sellers
| 1 | -$1.96M | |
| 2 | -$1.11M | |
| 3 | -$1.06M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$722K |
| 5 |
MTIM
Marathon Trading Investment Management
Radnor,
Pennsylvania
|
-$421K |